{"id":"https://openalex.org/W7197040366","doi":"https://doi.org/10.31782/ijcrr.2026.181301","title":"Global Regulatory Landscape of Orphan Drug Development: An Evaluation of Market Authorizations, Therapeutic Areas and Sponsor Companies","display_name":"Global Regulatory Landscape of Orphan Drug Development: An Evaluation of Market Authorizations, Therapeutic Areas and Sponsor Companies","publication_year":2026,"publication_date":"2026-01-01","ids":{"openalex":"https://openalex.org/W7197040366","doi":"https://doi.org/10.31782/ijcrr.2026.181301"},"language":"en","primary_location":{"id":"doi:10.31782/ijcrr.2026.181301","doi":"https://doi.org/10.31782/ijcrr.2026.181301","is_oa":true,"landing_page_url":"https://doi.org/10.31782/ijcrr.2026.181301","pdf_url":"https://doi.org/10.31782/ijcrr.2026.181301","source":{"id":"https://openalex.org/S2765045337","display_name":"International Journal of Current Research and Review","issn_l":"0975-5241","issn":["0975-5241","2231-2196"],"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":["poland-20"],"host_organization":"https://openalex.org/P4323867251","host_organization_name":"Radiance Research Academy","host_organization_lineage":["https://openalex.org/P4323867251"],"host_organization_lineage_names":["Radiance Research Academy"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International Journal of Current Research and Review","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"diamond","oa_url":"https://doi.org/10.31782/ijcrr.2026.181301","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5144637430","display_name":"Dipti Vilas Sonawane","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Dipti Vilas Sonawane","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5145432501","display_name":"Pranjal Pramod Chaudhary","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Pranjal Pramod Chaudhary","raw_affiliation_strings":["Dadasaheb Balpande College of Pharmacy , Besa , Nagpur"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dadasaheb Balpande College of Pharmacy , Besa , Nagpur","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5070798876","display_name":"Aparna Bhalerao","orcid":"https://orcid.org/0000-0002-9098-9283","observed_orcids":["https://orcid.org/0000-0002-9098-9283"]},"institutions":[{"id":"https://openalex.org/I4405285342","display_name":"JSPM University","ror":"https://ror.org/058c3a641","country_code":"IN","type":"education","lineage":["https://openalex.org/I4405285342"]}],"countries":["IN"],"is_corresponding":false,"raw_author_name":"Aparna Bhalerao","raw_affiliation_strings":["School of Pharmaceutical Sciences , Faculty of Health Sciences , JSPM university , Pune ;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"School of Pharmaceutical Sciences , Faculty of Health Sciences , JSPM university , Pune ;","institution_ids":["https://openalex.org/I4405285342"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5045641887","display_name":"Ajay G. Pise","orcid":"https://orcid.org/0000-0003-1860-8383","observed_orcids":["https://orcid.org/0000-0003-1860-8383"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ajay G. Pise","raw_affiliation_strings":["Dadasaheb Balpande College of Pharmacy , Besa , Nagpur"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dadasaheb Balpande College of Pharmacy , Besa , Nagpur","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"18","issue":"13","first_page":"01","last_page":"09"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11792","display_name":"Pharmaceutical Economics and Policy","score":0.9570000171661377,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},"topics":[{"id":"https://openalex.org/T11792","display_name":"Pharmaceutical Economics and Policy","score":0.9570000171661377,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T13417","display_name":"Biomedical Ethics and Regulation","score":0.022099999710917473,"subfield":{"id":"https://openalex.org/subfields/2910","display_name":"Issues, ethics and legal aspects"},"field":{"id":"https://openalex.org/fields/29","display_name":"Nursing"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12547","display_name":"Pharmaceutical studies and practices","score":0.007000000216066837,"subfield":{"id":"https://openalex.org/subfields/2735","display_name":"Pediatrics, Perinatology and Child Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/orphan-drugs","display_name":"orphan drugs","score":0.9860000014305115},{"id":"https://openalex.org/keywords/rare-diseases","display_name":"rare diseases","score":0.9919999837875366},{"id":"https://openalex.org/keywords/drug-regulation","display_name":"drug regulation","score":0.6179999709129333},{"id":"https://openalex.org/keywords/regulatory-pathways","display_name":"regulatory pathways","score":0.8119999766349792},{"id":"https://openalex.org/keywords/drug-approval","display_name":"drug approval","score":0.9200000166893005},{"id":"https://openalex.org/keywords/regulatory-incentives","display_name":"regulatory incentives","score":0.972000002861023},{"id":"https://openalex.org/keywords/regulatory-harmonization","display_name":"regulatory harmonization","score":0.8130000233650208},{"id":"https://openalex.org/keywords/orphan-drug-development","display_name":"orphan drug development","score":0.48500001430511475},{"id":"https://openalex.org/keywords/market-access-barriers","display_name":"market access barriers","score":0.6819999814033508},{"id":"https://openalex.org/keywords/artificial-intelligence-in-drug-development","display_name":"artificial intelligence in drug development","score":0.7149999737739563},{"id":"https://openalex.org/keywords/gene-therapy","display_name":"gene therapy","score":0.9980000257492065},{"id":"https://openalex.org/keywords/precision-medicine","display_name":"precision medicine","score":0.9919999837875366},{"id":"https://openalex.org/keywords/international-regulatory-cooperation","display_name":"international regulatory cooperation","score":0.9020000100135803},{"id":"https://openalex.org/keywords/fda","display_name":"FDA","score":0.671999990940094},{"id":"https://openalex.org/keywords/ema","display_name":"EMA","score":0.9800000190734863},{"id":"https://openalex.org/keywords/pyromellitic-dianhydride","display_name":"pyromellitic dianhydride","score":0.9660000205039978},{"id":"https://openalex.org/keywords/tga","display_name":"TGA","score":0.9890000224113464},{"id":"https://openalex.org/keywords/cdsco","display_name":"CDSCO","score":0.9980000257492065}],"concepts":[{"id":"https://openalex.org/C75480439","wikidata":"https://www.wikidata.org/wiki/Q1367466","display_name":"Orphan drug","level":2,"score":0.9398999810218811},{"id":"https://openalex.org/C144133560","wikidata":"https://www.wikidata.org/wiki/Q4830453","display_name":"Business","level":0,"score":0.6459000110626221},{"id":"https://openalex.org/C3019398576","wikidata":"https://www.wikidata.org/wiki/Q1639780","display_name":"Regulatory agency","level":2,"score":0.6395999789237976},{"id":"https://openalex.org/C108170787","wikidata":"https://www.wikidata.org/wiki/Q3951828","display_name":"Agency (philosophy)","level":2,"score":0.6334999799728394},{"id":"https://openalex.org/C108759981","wikidata":"https://www.wikidata.org/wiki/Q788590","display_name":"Authorization","level":2,"score":0.6209999918937683},{"id":"https://openalex.org/C29122968","wikidata":"https://www.wikidata.org/wiki/Q1414816","display_name":"Incentive","level":2,"score":0.613099992275238},{"id":"https://openalex.org/C3018890749","wikidata":"https://www.wikidata.org/wiki/Q204711","display_name":"Food and drug administration","level":2,"score":0.5278000235557556},{"id":"https://openalex.org/C2777589142","wikidata":"https://www.wikidata.org/wiki/Q6770899","display_name":"Marketing authorization","level":2,"score":0.5181999802589417},{"id":"https://openalex.org/C2777481183","wikidata":"https://www.wikidata.org/wiki/Q6770787","display_name":"Market access","level":3,"score":0.41440001130104065},{"id":"https://openalex.org/C64903051","wikidata":"https://www.wikidata.org/wiki/Q2198549","display_name":"Drug development","level":3,"score":0.3580999970436096},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.32519999146461487},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.30649998784065247},{"id":"https://openalex.org/C2778917124","wikidata":"https://www.wikidata.org/wiki/Q7309705","display_name":"Regulatory science","level":2,"score":0.30630001425743103},{"id":"https://openalex.org/C2910001868","wikidata":"https://www.wikidata.org/wiki/Q458","display_name":"European union","level":2,"score":0.3050000071525574},{"id":"https://openalex.org/C2777424817","wikidata":"https://www.wikidata.org/wiki/Q35456","display_name":"Essential medicines","level":3,"score":0.30239999294281006},{"id":"https://openalex.org/C100001284","wikidata":"https://www.wikidata.org/wiki/Q2248246","display_name":"Public economics","level":1,"score":0.2847999930381775},{"id":"https://openalex.org/C46578552","wikidata":"https://www.wikidata.org/wiki/Q2725393","display_name":"Global health","level":3,"score":0.2782999873161316},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.27810001373291016},{"id":"https://openalex.org/C2992293740","wikidata":"https://www.wikidata.org/wiki/Q4781752","display_name":"Drug approval","level":3,"score":0.27160000801086426},{"id":"https://openalex.org/C3019422483","wikidata":"https://www.wikidata.org/wiki/Q1646605","display_name":"Member states","level":3,"score":0.26919999718666077},{"id":"https://openalex.org/C2779701055","wikidata":"https://www.wikidata.org/wiki/Q929833","display_name":"Rare disease","level":3,"score":0.26820001006126404},{"id":"https://openalex.org/C30455989","wikidata":"https://www.wikidata.org/wiki/Q1047494","display_name":"Domestic market","level":2,"score":0.2671999931335449},{"id":"https://openalex.org/C150903083","wikidata":"https://www.wikidata.org/wiki/Q7108","display_name":"Biotechnology","level":1,"score":0.2635999917984009},{"id":"https://openalex.org/C2987276129","wikidata":"https://www.wikidata.org/wiki/Q12140","display_name":"Drug administration","level":2,"score":0.26080000400543213},{"id":"https://openalex.org/C2780765947","wikidata":"https://www.wikidata.org/wiki/Q12033531","display_name":"Administration (probate law)","level":2,"score":0.2547999918460846}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.31782/ijcrr.2026.181301","doi":"https://doi.org/10.31782/ijcrr.2026.181301","is_oa":true,"landing_page_url":"https://doi.org/10.31782/ijcrr.2026.181301","pdf_url":"https://doi.org/10.31782/ijcrr.2026.181301","source":{"id":"https://openalex.org/S2765045337","display_name":"International Journal of Current Research and Review","issn_l":"0975-5241","issn":["0975-5241","2231-2196"],"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":["poland-20"],"host_organization":"https://openalex.org/P4323867251","host_organization_name":"Radiance Research Academy","host_organization_lineage":["https://openalex.org/P4323867251"],"host_organization_lineage_names":["Radiance Research Academy"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International Journal of Current Research and Review","raw_type":"journal-article"}],"best_oa_location":{"id":"doi:10.31782/ijcrr.2026.181301","doi":"https://doi.org/10.31782/ijcrr.2026.181301","is_oa":true,"landing_page_url":"https://doi.org/10.31782/ijcrr.2026.181301","pdf_url":"https://doi.org/10.31782/ijcrr.2026.181301","source":{"id":"https://openalex.org/S2765045337","display_name":"International Journal of Current Research and Review","issn_l":"0975-5241","issn":["0975-5241","2231-2196"],"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":["poland-20"],"host_organization":"https://openalex.org/P4323867251","host_organization_name":"Radiance Research Academy","host_organization_lineage":["https://openalex.org/P4323867251"],"host_organization_lineage_names":["Radiance Research Academy"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International Journal of Current Research and Review","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.6240000128746033},{"id":"https://metadata.un.org/sdg/17","display_name":"Partnerships for the goals","score":0.5217000246047974}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W7197040366.pdf","grobid_xml":"https://content.openalex.org/works/W7197040366.grobid-xml"},"referenced_works_count":2,"referenced_works":["https://openalex.org/W4385552594","https://openalex.org/W4408552477"],"related_works":["https://openalex.org/W4411695054","https://openalex.org/W7217973821","https://openalex.org/W7131667268","https://openalex.org/W6968321567","https://openalex.org/W4309175815","https://openalex.org/W6930808648","https://openalex.org/W4411487873","https://openalex.org/W4377099499","https://openalex.org/W3214377933","https://openalex.org/W7038057202"],"abstract_inverted_index":{"Rare":[0],"diseases":[1,167],"represent":[2],"a":[3,53],"significant":[4],"global":[5,60,146],"healthcare":[6],"challenge":[7],"due":[8],"to":[9,31,150],"their":[10,38],"low":[11],"prevalence,":[12],"delayed":[13],"diagnosis,":[14],"limited":[15],"treatment":[16,20],"options,":[17],"and":[18,40,47,66,78,87,96,118,134,144,155,159],"high":[19],"costs.":[21],"Orphan":[22],"drugs":[23,162],"have":[24],"emerged":[25],"as":[26,127],"an":[27],"essential":[28,149],"therapeutic":[29],"approach":[30],"address":[32],"these":[33],"unmet":[34],"medical":[35],"needs;":[36],"however,":[37],"development":[39],"market":[41,63,119],"authorization":[42,64],"require":[43],"specialized":[44],"regulatory":[45,61,67,71,136,140],"pathways":[46],"supportive":[48],"incentives.":[49],"This":[50],"review":[51],"provides":[52],"comprehensive":[54],"overview":[55],"of":[56,157],"orphan":[57,111,161],"drug":[58,112],"development,":[59,113,153],"pathways,":[62],"processes,":[65],"incentives":[68],"across":[69],"major":[70,107],"authorities,":[72],"including":[73,114],"the":[74,106,152],"United":[75],"States":[76],"Food":[77],"Drug":[79],"Administration":[80,94],"(USFDA),":[81],"European":[82],"Medicines":[83],"Agency":[84,90],"(EMA),":[85],"Pharmaceuticals":[86],"Medical":[88],"Devices":[89],"(PMDA),":[91],"Therapeutic":[92],"Goods":[93],"(TGA),":[95],"Central":[97],"Drugs":[98],"Standard":[99],"Control":[100],"Organisation":[101],"(CDSCO).":[102],"It":[103],"further":[104],"discusses":[105],"challenges":[108],"associated":[109],"with":[110,165],"clinical,":[115],"regulatory,":[116],"manufacturing,":[117],"access":[120],"barriers,":[121],"while":[122],"highlighting":[123],"emerging":[124],"opportunities":[125],"such":[126],"artificial":[128],"intelligence,":[129],"gene":[130],"therapy,":[131],"precision":[132],"medicine,":[133],"international":[135],"collaboration.":[137],"Overall,":[138],"strengthening":[139],"harmonization,":[141],"fostering":[142],"innovation,":[143],"enhancing":[145],"collaboration":[147],"are":[148],"improve":[151],"approval,":[154],"accessibility":[156],"safe":[158],"effective":[160],"for":[163],"patients":[164],"rare":[166],"worldwide.":[168]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2026-08-07T00:00:00"}